Laurus Labs Q4 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
2,059.00
39.00 (1.93%)
39.00 (1.93%)Volume1.03 L
Updated: Fri 16 Oct, 2026 | 15:59:49
NSE
2,060.1041.60 (2.06%)
41.60 (2.06%)Volume1.61 M
Updated: Fri 16 Oct, 2026 | 15:51:09
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Laurus Labs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,421.56 | 1,418.70 | 0.20% | 1,300.43 | 0.81% |
| Depreciation/ Amortization | 122.10 | 120.62 | 1.23% | 102.25 | 10.57% |
| Operating Income | 390.01 | 359.59 | 8.46% | 139.24 | 25.74% |
| Net Income | 279.14 | 251.66 | 10.92% | 75.61 | 19.46% |
| Other Operating Expenses Total | 363.51 | 374.27 | -2.87% | 315.06 | 7.13% |
| Net Income Before Taxes | 361.37 | 326.56 | 10.66% | 107.27 | 15.70% |
| Total Revenue | 1,811.57 | 1,778.29 | 1.87% | 1,439.67 | 5.31% |
| Selling/ General/ Admin Expenses Total | 235.85 | 229.24 | 2.88% | 161.11 | 32.72% |
| Diluted Normalized EPS | 5.17 | 4.65 | 11.08% | 1.40 | 19.26% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.